Directory
>
Laura Tadvalkar
Laura Tadvalkar
Board Director | Cidara Therapeutics
Boston, Massachusetts, United States
Laura Tadvalkar
Summary
Laura Tadvalkar is a seasoned professional in the biopharmaceutical industry, currently serving as the Managing Director at RA Capital. With a strong academic background, including a Ph.D. from Harvard University, she has cultivated extensive expertise in biochemistry, molecular biology, and oncology. Laura has held numerous leadership roles on boards of various biotech firms, showcasing her commitment to innovation and strategic growth in healthcare. Her experience spans both corporate and consulting environments, where she has developed launch strategies and opportunity assessments for emerging therapies. Laura is recognized for her contributions to the field, receiving multiple awards including the NSF Graduate Research Fellowship. Beyond her impressive career, she is passionate about mentoring the next generation of scientists and leaders in the biotech space.
Laura Tadvalkar
Work Experience
Board Director at
Cidara Therapeutics
April 2024 - Present
Managing Director at
RA Capital Management
April 2023 - Present
Board Director at
Typewriter Therapeutics, Inc.
January 2023 - Present
Board Director at
Hemab Therapeutics
January 2021 - Present
Board Director at
Hyku Biosciences Inc.
January 2021 - Present
Board Chair at
Ana Therapeutics, LLC
January 2021 - Present
Board Director at
Expansion Therapeutics
January 2021 - Present
Board Observer at
Pepgen Securities Corp.
January 2020 - Present
Board Director, Former Board Observer at
Be Biopharma
January 2020 - Present
Board Director, Former Board Observer at
Mariana Oncology
January 2021 - January 2024
Principal at
RA Capital Management
December 2020 - April 2023
Kauffman Fellow, Class 23 at
Kauffman Fellows
January 2018 - January 2021
Board Observer at
Aerovate Therapeutics, Inc.
January 2020 - January 2021
Venture Senior Associate at
RA Capital Management
April 2020 - December 2020
Principal at
Mp Healthcare Venture Management, Inc.
May 2019 - April 2020
Board Observer at
QurAlis
January 2019 - January 2020
Board Observer at
Sonde Health, Inc.
January 2019 - January 2020
Board Observer, Interim Director of BD at
Ribometrix Inc.
January 2017 - January 2020
Senior Associate at
Mp Healthcare Venture Management, Inc.
March 2017 - May 2019
Manager at
Clarion
January 2017 - March 2017
Consultant at
Clarion
July 2015 - December 2016
Associate Consultant at
Clarion
September 2014 - June 2015
Ph.D. in Chemical Biology at
Harvard University
September 2009 - May 2014
Undergraduate Researcher at
Yale University Press
May 2008 - May 2009
Laura Tadvalkar
Education
Harvard University, Doctor Of Philosophy (Ph.D.)
January 2009 - January 2014
Yale University, Bs, Cum Laude
January 2005 - January 2009
Frequently Asked Questions about Laura Tadvalkar
What is Laura Tadvalkar email address?
Laura Tadvalkar's primary email address is **********@racap.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Laura Tadvalkar work for?
Laura Tadvalkar is a Board Director at Cidara Therapeutics, a company specializing in Biological products, except diagnostic.
Where Laura Tadvalkar graduated from?
Laura Tadvalkar holds a degree in Chemical Biology from Harvard University.
How can I directly contact Laura Tadvalkar?
To contact Laura Tadvalkar directly, you can use the email address **********@racap.com. Complete contact information is available upon registration with Muraena.
Who is Laura Tadvalkar?
Laura Tadvalkar is a seasoned professional in the biopharmaceutical industry, currently serving as the Managing Director at RA Capital. With a strong academic background, including a Ph.D. from Harvard University, she has cultivated extensive expertise in biochemistry, molecular biology, and oncology. Laura has held numerous leadership roles on boards of various biotech firms, showcasing her commitment to innovation and strategic growth in healthcare. Her experience spans both corporate and consulting environments, where she has developed launch strategies and opportunity assessments for emerging therapies. Laura is recognized for her contributions to the field, receiving multiple awards including the NSF Graduate Research Fellowship. Beyond her impressive career, she is passionate about mentoring the next generation of scientists and leaders in the biotech space.
Laura`s contact details
**********@racap.com
***************@harvard.edu